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Developing organs require iron for a myriad of func-
tions, but embryos deleted of the major adult trans-
port proteins, transferrin or its receptor transferrin
receptor1 (TfR1/), still initiate organogenesis, sug-
gesting that non-transferrin pathways are important.
To examine these pathways, we developed chimeras
composed of fluorescence-tagged TfR1/ cells and
untagged wild-type cells. In the kidney, TfR1/
cells populated capsule and stroma, mesenchyme
and nephron, but were underrepresented in ureteric
bud tips. Consistently, TfR1 provided transferrin to
the ureteric bud, but not to the capsule or the stroma.
Instead of transferrin, we found that the capsule
internalized ferritin. Since the capsule expressed
a novel receptor called Scara5, we tested its role in
ferritin uptake and found that Scara5 bound serum
ferritin and then stimulated its endocytosis from the
cell surface with consequent iron delivery. These
data implicate cell type-specific mechanisms of iron
traffic in organogenesis, which alternatively utilize
transferrin or non-transferrin iron delivery pathways.
INTRODUCTION
Iron travels from the placenta to embryonic organs bound to
carrier proteins, such as transferrin, which is detectable in extra-
cellular fluids by mid-gestation in rodents (Gustine and Zimmer-
man, 1973). Transferrin is then captured throughout the embryo
by the transferrin receptor (TfR1). This pathway is essential for
development, since deletion of TfR1 resulted in embryonic death
at E11-E12 (Levy et al., 1999). Indeed, during kidney develop-
ment, transferrin was found to be both necessary and sufficient
to stimulate tubulogenesis in vitro, suggesting a critical role for
transferrin-mediated iron transport in nephrogenesis (Ekblom
et al., 1983) and by extension perhaps to the development of
other organs. The widespread expression of TfR1 (Aisen, 2004)Devfurther reinforced the view that transferrin plays a critical role
throughout the embryo.
A detailed analysis of specific embryonic lineages, however,
suggests a more restricted view of the transferrin pathway.
Transferrin is necessary for thymic maturation (Brekelmans
et al., 1994; Ned et al., 2003;Macedo et al., 2004) but this require-
ment is stage specific, since TfR1 neutralizing antibodies block
the progression of double negative thymocytes, but fail to inhibit
earlier stagesof the lymphoid lineage, despite the fact that TfR1 is
expressed at all stages. Likewise, while TfR1/ embryos (Levy
et al., 1999) have specific defects in erythroid, lymphoid, and
spinal cord development, most other organs appear to initiate
development. Chimeras composed of TfR1/ and wild-type
ES cells can live into adulthood, and TfR1/ cells can be de-
tected by Southern blots in a variety of organs, confirming the
notion that different cells can arise from TfR1/ ES cells in vivo
(Ned et al., 2003). Similarly, apparently normal organogenesis
occurs in hypotransferrinemic micehpx/hpx (Huggenvik et al.,
1989; Trenor et al., 2000) andhumans (Hayashi et al., 1993;Hamill
et al., 1991), despite severe anemia. Hence, while specific stages
of the hematopoeitic lineage (Kanayasu-Toyoda et al., 1999;
Sposi et al., 2000; Wingert et al., 2004), bone (Gentili et al.,
1994), and nervous system (Siddappa et al., 2002; Levy et al.,
1999) depend on TfR1, other cells in the embryo may capture
iron by a non-transferrin mechanism. However, few non-trans-
ferrin iron trafficking molecules are known, and knockouts of
non-transferrin carriers including Lcn2 (Flo et al., 2004), and
iron uptake proteins such as DMT1 (Gunshin et al., 2005) and
Steap3 (Ohgami et al., 2005), do not grossly disrupt organogen-
esis. These data leave many fundamental questions unresolved,
such as the identity of other iron carriers, their receptors that
deliver iron into an appropriate intracellular compartment, and
whether different pathways of iron delivery are cell-specific.
Ferritin is a major iron storage protein. Intracellular ferritin is
composed of 24 subunits of L- and H-chains in varied proportion
(Arosio and Levi, 2002). On the other hand, extracellular (serum)
ferritin is composed mostly, but not exclusively of L-ferritin
(Linder et al., 1996; Ghosh et al., 2004). Secretion of L-ferritin
has been carefully documented in cell cultures (Tran et al.,
1997; Ghosh et al., 2004) and in syndromes which overexpresselopmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc. 35
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Iron Traffic in the MetanephrosFigure 1. Initial Stages of Renal Development Were Preserved in TfR1/ Mice
(A and B) (A) Pax2+ Wolffian ducts and mesonephros and (B) Pax2+ ureteric buds surrounded by mesenchymal cells were detected in TfR1/ E11 embryos.
Crosses with Hoxb7-GFP mice distinguished the ureteric bud (GFP+Pax-2+) from mesenchyme (GFPPax-2+). Bar = 10 mm.L-chain, such as heterozygous H chain-deficient mice (Ferreira
et al., 2001), hpx/hpx mice (Simpson et al., 1991; Dickinson
and Connor, 1995), and humans with hyperferritinemia and cata-
racts (Beaumont et al., 1995). Cytokine stimulation of some cell
types also induces H-ferritin secretion (Tran et al., 1997), partic-
ularly from macrophages (Chen et al., 2005; Recalcati et al.,
2008). While the two chains of ferritin have complementary func-
tions [H-ferritin is a ferroxidase (Levi et al., 1988) and L-ferritin
induces polynucleation of iron (Levi et al., 1994)], both ferritins
can independently incorporate iron into a core. For example,
while serum-ferritin is iron-poor compared to intracellular ferritin,
it contains 7 iron atoms/molecule (Watanabe et al., 2001), similar
to bacterially expressed L-ferritin, which contains 5–15 iron
atoms/molecule (Levi et al., 1989, 1992). In the presence of
even a single H chain, up to 4500 iron atoms can be incorporated
into L-ferritin cages.
Extracellular ferritin can deliver iron to a variety of cells. Ferritin
can bind cell surface receptors, undergo endocytosis, and trans-
fer of iron in sufficient quantities to alter iron-dependent gene
expression (Ponka et al., 1998). A receptor for H-ferritin has
been identified, Tim2 (or Timd2; Chen et al., 2005), but its expres-
sion is highly restricted in the embryo. In contrast, receptors for
L-ferritin have not been documented, but may in fact be particu-
larly relevant in the embryo, whose serum ferritin concentration is
3–8-fold greater than that of maternal blood (Bratlid and Moe,
1980; Hussain et al., 1977; MacPhail et al., 1980; Puolakka
et al., 1980).
To clarify the mechanisms of iron delivery in embryogenesis,
we developed an in vivo assay to evaluate the requirement for
TfR1. We focused on the embryonic kidney where cell type
progression is dependent on iron delivery (Ekblom et al., 1983).
Using chimeric embryos composed of green fluorescent protein
(GFP)-labeled TfR1/ cells (GFP-TfR1/ cells) and unlabeled
wild-type cells, we found that mesenchymal, stromal, and
capsule compartments were robustly populated by GFP-
TfR1/ cells and accumulated iron independently of TfR1.
Capsular cells expressed Scara5 (Jiang et al., 2006), which we
found bound extracellular ferritin, mediated its endocytosis,36 Developmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevierand captured its iron. Tips of the branching ureteric bud on the
other hand were poorly populated by GFP-TfR1/ cells, con-
firming a cell type-specific, rather than a global requirement,
for transferrin-TfR1. These data imply that different mechanisms
deliver iron to different cell types in the developing kidney.
RESULTS
Evidence for Transferrin and Non-Transferrin Iron
Delivery in Kidney Development
The developing kidney is generated from three cellular lineages,
epithelial (including the nephric duct, ureteric bud [UB], and
collecting ducts), metanephric mesenchyme (composed of
cap mesenchyme, pretubular aggregate, renal vesicle, C-and
S-shaped bodies, and nascent nephron) and a stromal compart-
ment (composed of the capsule, cortical and medullary stroma).
The ureteric bud generates a branched collecting duct system.
The mesenchymal lineage converts to epithelia and gives rise
to both mesonephric and metanephric nephrons, containing
glomeruli and epithelial tubules. Capsular and stromal cells
form the outermost rings of cells in the kidney cortex and are
composed of a variety of cells that have yet to be fully defined
(Dressler, 2006; Hatini et al., 1996; Levinson and Mendelsohn,
2003; Schmidt-Ott et al., 2006).
To investigate pathways of iron delivery in the developing
kidney, we first inspected TfR1+/ 3 TfR1+/ crosses (Levy
et al., 1999; Ned et al., 2003). We examined 210 E11 embryos
recovering TfR1+/+ (28%), TfR1+/ (52%), and TfR1/ (20%) in
approximate Mendelian ratios. TfR1/ embryos contained the
Wolffian duct and associated mesonephric tubules (Figure 1A).
The embryos also developed ureteric buds from the Wolffian
duct (marked by creating Tfr1/; Hoxb7-GFP+ lines; Srinivas
et al., 1999) as well as cap mesenchyme (Figure 1B). In rare,
surviving embryos at E11.5, elongated T-shaped UBs and renal
vesicles were found (Figure S1, see the Supplemental Data
available online), but more advanced ureteric branching and
mesenchymal-epithelial development could not be assayed
due to the lethality of TfR1 knockout.Inc.
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Iron Traffic in the MetanephrosFigure 2. Development of GFP-TfR1/ Cells in E15 Kidney
(A) GFP-TfR1/ cells were readily detected in capsule and stroma,mesenchyme, renal vesicles, and S-shaped bodies, but detected with limited frequency in UB
tips (bar = 10 mm).
(B) GFP-TfR1/cells (42%) reside in the capsule, interstitium, and podocalyxin+ vascular progenitors (confocal section; bar = 10 mm).
(C and D) GFP-TfR1/ cells (58%) also resided in proximal and distal nephrons (Ecadherin+; dark blue), in podocytes (podocalyxin+; red, Glm = glomerulus) and
in the UB stalk (Ecadherin+, dark blue; Troma+, pink). In some cases, entire segments of the S-shaped body were composed of GFP-TfR1/ cells (confocal
section; bar = 10 mm).
(E and F) Genes specific for UB tip or mesenchymal-stromal compartments were assayed in GFP-TfR1/ and wild-type cells and presented as the log2 ratio of
microarray values. UB tip-specific genes were under represented in GFP-TfR1/ cells, whereas mesenchymal-stromal genes were expressed.
(G) Both GFP-TfR1/ and wild-type cells (two sections are shown) contained cytoplasmic ferritin.
(H) Wild-type cells captured Alexa568-transferrin, but neighboring GFP-TfR1/ were unlabeled. Bar = 10 mm.To determine whether TfR1/ renal progenitors were compe-
tent to form organotypic structures, we used an in vitro culture
system. As shown in Figure S2, when TfR1/ urogenital sheets
(E11) were explanted and the media were supplemented with
ferric ammonium citrate (20 mg/ml), a TfR1-independent iron
donor, the sheet consistently generated highly branched ureteric
buds surmounted by cap mesenchyme (n = 21 urogenital
sheets), whereas culture with transferrin resulted in regression
of the tissue. This implied that urogenital progenitors, present
in vivo when the sheet was explanted (E11) remained competent
to form kidney-specific structures despite the deletion of TfR1.
To test the functional requirement for transferrin in vivo beyond
the E11 stage, we created chimeric embryos by injecting TfR1/
ES cells into wild-type blastocysts. TfR1/ ES cells (Ned et al.,
2003) were labeled by targeting the Rosa26 locus with GFP (Srini-
vas et al., 2001) and two different clones were utilized in subse-
quent experiments. The knock in of GFP was confirmed by
Southern blotting, and the deletion of TfR1 was confirmed by
aseriesofassays that includedgenotyping,measuringcell surface
TfR1 proteinwithCD71 antibodies, and incubationwith Alexa568-
transferrin, which showed that GFP targeted TfR1/ ES cells
neither expressed TfR1 nor captured transferrin (Figure S3).
The GFP-TfR1/ cells populated many embryonic organs
including lung, liver, mid-gut, kidney, bladder, and gonad, and
within these tissues, GFP-TfR1/ produced both epithelia
(including branching and sheet structures) and mesenchymal
precursors (Figure S4), demonstrating the multipotency of the
GFP-TfR1/ cells.DevIn the kidney, we found extensive chimerism in the Wolffian
ducts and the metanephric mesenchyme, as expected from
our observation of early kidney structures in TfR1/ embryos
at E11.5 (Figure S5). At the E15 stage, GFP-TfR1/ cells were
also present throughout the kidney (Figure 2, Figure S5; n = 14
total foster mothers, using two clones of GFP-TfR1/ ES cells).
To examine the contribution of the GFP-TfR1/ cells to indi-
vidual compartments, we compared the percentage of GFP+
cells found in each compartment, to the relative size of the
compartment, measured by planimetry. The GFP-TfR1/ cells
populated distal tubules (identified by staining for E-cadherin;
median ratio = 1.7; p = 0.0001), proximal tubules (which stained
with lotus lectin; median ratio = 1.930; p = 0.0425) and the stroma
and capsule, which contained as much as 42% ± 17% of the
GFP-TfR1/ cells (median ratio = 4.1; p < 0.001), even though
these compartments account for only 6%–9% of the cells in
the E15 kidney (as estimated by FACS analysis of kidneys
expressing Foxd1-GFP). In contrast to these findings, cortical
tips of the ureteric bud (highlighted by the expression of both
E-cadherin and Troma1) contained the fewest GFP-TfR1/ cells
(median ratio = 0.43; p = 0.003), even in kidneys with high overall
degrees of chimerism (Figure 2, Figures S5 and S6). The exclu-
sion of GFP-TfR1/ cells from the UB tip contrasted with
chimeras generated with GFP-TfR1+/+ ES cells, which populated
all compartments including UB tips (p = 0.78; Figure S7).
To confirm the anatomical distribution of GFP-TfR1/ cells,
we used FACS to separate GFP-TfR1/ from wild-type cells
using two different sets of kidneys (E15) with high degrees ofelopmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc. 37
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Iron Traffic in the Metanephroschimerism (60%)andmeasuredgeneexpressionusingAffyme-
trix arrays (Mouse Genome 430 2.0). In agreement with prior
studies (Levy et al., 1999; Ned et al., 2003), GFP-TfR1/ cells
were incompetent to participate in erythroid and granulocytic
lineages: erythroid (hemoglobin, aminolevulinic acid synthase 2)
and granulocytic (lactoferrin, neutrophil granule protein) genes
were reduced on average 14-fold in GFP-TfR1/ compared to
TfR1+/+ cells. Similarly, genespreferentially expressedbyureteric
bud tips (Wnt11, Wnt9B, Cytokine Receptor Like Factor1, Ros1;
Kanwar et al., 1995; Kispert et al., 1996; Marose et al., 2008;
Schmidt-Ott et al., 2005) were decreased to 0.35 ± 0.27 fold
(TfR1/ versus TfR1+/+). On the contrary, genes expressed in
renal stroma (FGF-7, SFRP1, Semaphorin3A, Glypican3,
FoxD1, Angiotensin II receptor, type 2) and capsule (Col6a1,
Col5A2, Nfix) were increased 2.9 ± 0.8- and 2.7 ± 0.26-fold, in
GFP-TfR1/ versus TfR1+/+ cells, respectively (data not shown).
These data were extended by analyzing a series of genes
restricted to UB tip, stalk, or the mesenchyme-stroma compart-
ment, that we identified by expression profiling (Schmidt-Ott
et al., 2005). This comparison showedmarkedly reduced expres-
sion of the top 200 ureteric tip-specific genes in GFP-TfR1/
cells isolated from E15 chimeric kidneys, when compared with
the TfR1+/+ population (0.42-fold; p = 0.0000921; Figure 2E). In
contrast, the expression of the top 200 UB stalk-specific genes
was only slightly reduced (0.71-fold; p = 0.00265), while the
expression of the top 200 mesenchymal-stromal-specific genes
was unchanged (1.2-fold; p = 0.253; Figure 2F). These data
confirmed the preferential location of GFP-TfR1/ cells in
mesenchyme and stroma, particularly compared to ureteric tip.
While it may be the case that the surviving GFP-TfR1/ cells
were severely iron-deficient, this was unlikely because, as shown
in Figure 2G, they displayed cytoplasmic iron stores (intracellular
ferritin). In addition,GFP-TfR1/cells demonstrated only slightly
reduced proliferation (as detected by phospho-histone H3 stain-
ing median ratio = 0.69, p = 0.0051) compared to neighboring
wild-type cells, and the same frequency of apoptosis (as
Figure 3. Ferritin Capture, Cell Prolifera-
tion, and Scara5 Expression in the Capsule
of the E15 Kidney
(A and B) Both wild-type and GFP-TfR1/
capsular cells captured rhodamine coupled
‘‘Exogenous L-Ferritin.’’ Bars = 20 mm.
(C andD) (C) Holoferritin (+HF; 1.25 mg/ml) induced
phosphohistone+ nuclei and expanded layers of
capsular cells, whereas culture with apoferritin
(HF;1.25mg/ml) failed topreserve thecapsule (D).
(E) ‘‘Endogenous Ferritin’’ was present throughout
the kidney, particularly in the capsule. E-cadherin
marked the UB.
(F) Scara5 RNAwas expressed by spindle-shaped
cells encapsulating the kidney (arrowheads) and
more faintly by cortical stroma.
detected by activated caspase-3 stain-
ing; p = 0.26). These findings imply that
GFP-TfR1/cells were not severely
iron-starved. Yet, in situ, these cells failed
to capture Alexa568-transferrin (Fig-
ure 2H), implying that they did not express
an alternative transferrin receptor. These data suggested that
transferrin-independent mechanisms of iron capture were active
in GFP-TfR1/ cells.
Endocytosis of Transferrin and Ferritin by Different
Cellular Compartments in Developing Kidney
Extracellular ferritin is a non-transferrin iron carrier that is endo-
cytosed by a variety of cells, including squamous-like cells of the
adult kidney capsule (Kobayashi, 1978). To investigate ferritin
capture by embryonic kidney, we incubated E15 kidneys with
Alexa568-apo-ferritin, and found prominent endocytosis of
ferritin by capsular cells. The capture of ferritin was independent
of TfR1 because both wild-type and GFP-TfR1/ cells captured
ferritin (Figures 3A and 3B). Ferritin L-chain was recognized by
the cells, because the pattern of uptake was reproduced by L-
but not by H-ferritin. To determine whether ferritin transferred
its iron to the cell cytoplasm, we incubated explanted kidneys
in the presence of either iron-loaded ferritin (holo-ferritin) or
iron-deprived ferritin (apo-ferritin) and assayed proliferation in
the capsular region. When holo-ferritin was administered to
explanted kidneys, 49% of capsular nuclei expressed the prolif-
eration marker phospho-histone H3, whereas apo-ferritin
induced labeling in only 12% of nuclei (p = 0.04; Figures 3C
and 3D), implying that ferritin-mediated iron delivery determined
the cellularity of the renal capsule. Consistently, prominent
staining for endogenous ferritin (Figure 3E) implied ongoing
iron accumulation in the capsule in vivo.
Ferritin uptake was quite different from that of transferrin. TfR1
was largely restricted to the ureteric bud, cap mesenchyme, and
primitive nephron (Figures 4A–4C), identical to sites where trans-
ferrin was captured (Figure 4D). In contrast, capsule and stroma
demonstrated limited endocytosis of transferrin, even though
they were capable of endocytosis of fluid phase fluorescent
dextran (Figure 4E). These results demonstrate that ferritin and
transferrin receptors are both present in developing kidney, but
that they mediate iron transport to different cell types.38 Developmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc.
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The robust chimerism of GFP-TfR1/ cells in the stroma and
capsule suggested that they must capture non-transferrin
iron, perhaps including ferritin. To examine this possibility, we
isolated GFP-TfR1/cells by FACS and profiled their gene
expression. We found that 156 genes were consistently upregu-
lated R2-fold in the GFP-TfR1/ population compared with
wild-type cells (data not shown), but only one of these, scav-
enger receptor, member 5 (Scara5) was markedly upregulated
(7.1-fold in GFP-TfR1/ versus TfR1+/+; p = 0.0011) and shown
by in situ hybridization to be specifically located in a rim of cells
where ferritin was captured in both embryonic (Figure 3F) and
adult kidney (data not shown). Scara5 was also present in the
airway, the developing aorta, and muscle bundles, and it was
heavily expressed by gonadal epithelia (Figure S8; Jiang et al.,
2006).
To directly test whether ferritin might be a ligand for Scara5,
we expressed V5-tagged Scara5 in Trvb cells, a cell line that
lacks endogenous expression Scara5 and Tfr1 (McGraw et al.,
1987). Transiently transfected cells internalized apo-ferritin
(Figure 5A), while Trvb cells transfected with a control vector
did not (data not shown). Trvb clones (D2 and H2) that stably
overexpressed Scara5 also demonstrated enhanced ferritin
uptake compared to parental cells (Figure 5B) or clones (B2)
that failed to express the protein. Western blots of these clones
showed that Scara5 was present as 59 KDa and 70 KDa proteins
(Figure 5C), suggesting posttranslational processing.
Todemonstrate that Scara5 binds ferritin at the cell surface,we
added native ferritin at 4C to MSC-1 cells overexpressing V5-
tagged Scara5. Using two-color immunofluorescence, we found
immunodetectable patches of V5 and ferritin on the surface of
nonpermeabilized cells (Figure 6A). Raising the temperature to
37C resulted in endocytosis of the ferritin, while inclusion
Figure 4. Localization of the Transferrin
Pathway
(A–C) TfR1 was initially localized to UB tips and
cap mesenchyme. By E13, renal vesicles also
expressed TfR1 (*B, C). TfR1 expression was
reduced or absent in glomeruli (‘‘G’’), stroma,
and capsule.
(D and E) (D) Rhodamine and (E) fluorescein trans-
ferrin endocytosis paralleled TfR1 expression.
Stroma and capsule were weakly labeled despite
active fluid-phase endocytosis (rhodamine-
dextran; [E]). (*Presumptive distal nephron; Bar =
10 mm).
of 100-fold excess unlabelled ferritin
blocked both binding and endocytosis
(Figure 6B). Scara5 coimmunoprecipi-
tated from clones D2 and H2 together
with ferritin-avidin, but not with avidin it-
self (Figure 6C). Immunoprecipitationwith
ferritin-avidin coated biotin beads pulled
down immunodetectable Scara5, but
avidin-coated biotin beads did not (Fig-
ure 6D). These data indicate that Scara5
and ferritin interact at the cell surface.
It is well known that scavenger receptors bind more than one
ligand, however to our knowledge iron-transporting proteins had
not been shown to bind to this class of receptors. Using our
stable Scara5-Trvb clones, we studied whether Scara5 recog-
nized a variety of iron carriers. L-ferritin was the preferred ligand;
addition of as little as 250 pmole of L-chain (equivalent to 10
pmoles of an L-chain complex) in the media led to detection of
ferritin in cellular vesicles of H2 and D2 clones but not in parental
Trvb cells nor in nonexpressing clone B2 (Figure 5D). Scavenger
receptors bind to their ligands using electrostatic interaction.
Because attachment of fluorescent probes to ferritin might
have altered its net charge, we tested ferritin attached to two
fluorophores, Alexa-568 which adds a negative charge and
Alexa488 and Rhodamine which adds a positive charge. The
uptake of these two types of ferritins resulted in similar levels
of Scara5-dependent endocytosis. Haptoglobin-hemoglobin
was also internalized by H2 and D2 clones, but the signal was
less distinct than that of L-ferritin (Figure S9). H-ferritin, in
contrast, was not captured, nor were transferrin, albumin, hemo-
pexin-heme, or lipocalin2:catecholate siderophore. Further,
Scara5 differed from other scavenger receptors since it did not
capture fluorescent acetylated LDL (Jiang et al., 2006). These
data suggest that among other potential ligands, Scara5 is
a receptor or a component of a receptor for L-ferritin.
Scara5 Expressing Cells Can Obtain Iron from Ferritin
To examine whether Scara5 can deliver iron to the cell, we incu-
bated Scara5 expressing D2 and H2 clones with ferritin loaded
with radioactive iron and found that there was a time-dependent
incorporation into the Scara5-expressing cells, but not into the
parental Trvb cell (Figure 7A). Iron was likely obtained after endo-
cytosis into an acidic compartment, because 4C or inhibition of
vacuolar H+ATPase with bafilomycin blocked iron capture andDevelopmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc. 39
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Iron Traffic in the MetanephrosFigure 5. Interaction between Scara5 and L-Ferritin
(A and B) (A) Transient transfection of Scara5-V5 (anti-V5, green) and (B) stable expression of Scara5-V5 resulted in the capture of Alexa568-ferritin ([A and B],
right panel), whereas parental Trvb, which are Scara5TfR1 cells, transfected with an empty vector were negative ([B] left panel). Tris-quenched Alexa568 dye
(no ferritin) was an additional control (middle panel).
(C) Expression of Scara5-V5 (59 KDa, 70 KDa) was detected by V5 monoclonal antibody.
(D) Endocytosis of Alexa568-ferritin was analyzed in Scara5 (Trvb, B2 clones) and Scara5+ (D2 and H2) stable clones. Nearly all D2 and H2 cells captured
apo- and L-ferritins, but not H-ferritin. Bar = 10 mm.ferritin traffic to lysosomes (Figures 7A and 7B). Consistent data
came from a MSC-1 reporter cell line which expressed endoge-
nous Scara5 as well as fluorescent proteins driven by iron
responsive elements (IRE, Li et al., 2004).Holoferritin upregulated
CFP encoded by a 50IRE reporter gene, and downregulated YFP
encoded by a 30IRE reporter gene, consistent with the transfer of40 Developmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Iiron to the cytoplasm (Figure 7C). In the presence of holoferritin
(2 mg/ml), the 50IRE/30IRE fluorescence ratio (1.58 ± 0.31) was
not significantly different (ratio = 3.8 ± 1.5; p = 0.19) from that of
cells incubated in media containing ferric ammonium citrate
(50 mM) and holotransferrin (20 mg/ml). Cells incubated in media
containing the iron chelator desferroxamine (20 mM) hadnc.
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Iron Traffic in the Metanephrosa significantly lower ratio (0.53 ± 0.09; p = 0.044) than cells incu-
bated with holoferritin. To test whether ferritin iron can enhance
cell survival under iron-limiting conditions in a Scara5-dependent
manner, we incubated clones (D2 or H2) in minimal iron-deficient
media supplemented with either holo- or apo-ferritin. Whereas
Trvb cellswere unresponsive to either protein (n = 8), holo-ferritin,
but not apo-ferritin, dose-dependently supported the survival of
Scara5 expressing cells as measured by GAPDH blots (Fig-
ure 7D). Together, these data show that ferritin can deliver iron
and regulate iron-dependent intracellular events in a Scara5-
dependent manner.
Scara5 Is an Endogenous Ferritin Uptake Pathway
To determine whether native Scara5 acts as a ferritin receptor,
we suppressed its message in MSC-1 cells by RNA interference.
We derived stable clones expressing short hairpin RNA (shRNA)
targeting Scara5 and then transfected these clones with Scara5
siRNA (Qiu et al., 2006). This protocol reduced Scara5 message
to 29 ± 3.0%. Control studies showed that LacZ shRNA plus
LacZ siRNA did not restrict the expression of Scara5 (110.5 ±
0.26% compared to nontransfected MSC-1 cells). The interfer-
ence with Scara5 expression inhibited fluorescein-ferritin endo-
Figure 6. Interaction between Scara5
and Ferritin at the Cell Surface
(A) Scara5-V5 (anti-V5; Cy2; green) and ferritin
(anti-ferritin; Cy3; red) colocalized at the surface
(Z stack; inset: single confocal section) of
Scara5-V5 transfected MSC-1 cells incubated
with untagged ferritin (2 hr; 4C). Toto3 marked
nuclei. Bar = 10 mm.
(B) Endocytosis of rhodamine-ferritin (30 hr; 37C;
top panel) was blocked by a 100-fold excess
untagged ferritin (bottom panel). Bar = 20 mm.
(C) V5 antibodies precipitated Scara5-V5 with
avidin tetramer-ferritin monomer (85 KDa) or
multimers (200 KDa > 250 KDa), but not with
unconjugated avidin. Irrelevant isotype matched
antibodies did not immunoprecipitate ferritin-
avidin nor were ferritin-avidin complexes recov-
ered without cell extracts.
(D) Scara5-V5 was detected in cell extracts (clone
D2) and in pull-downs with ferritin-avidin-biotin-
agarose beads, but not with avidin-biotin-
agarose-beads.
cytosis, measured by FACS (61 ± 0.1%
compared to LacZ targeted cells; n = 5;
p = 0.00093).
Chemical blockade of Scara5 with pol-
yanions further confirmed the interaction
with ferritin. Polyinosinic acid (PI; 50 mg/
ml) nearly abolished the capture of
Alexa488-ferritin by MSC-1 cells,
whereas polyguanylic acid (PG) and poly-
cytidylic acid (PC) were less effective
(Figure 7E) as previously demonstrated
for other ligands by Jiang et al. (2006).
Consistently, the transfer of iron from holo-ferritin to MSC-1 cells
was inhibited by PI, suppressing the ratio of iron reporters 50IRE-
CFP/30IRE-YFP (0.7 ± 0.06; holoferritin versus holoferritin+PI, p =
0.05) whereas PC was ineffective (1.2 ± 0.2; holoferritin versus
holoferritin+PC , p = 0.4). In contrast, PI did not block the
response of the iron reporters to ferric ammonium citrate (data
not shown). To demonstrate that this behavior was not unique
to the MSC-1 cells, we repeated the inhibition studies in clones
D2 and H2 and in explanted kidneys and found similar results.
In aggregate, our data demonstrate that Scara5 can act as
a ferritin receptor delivering iron to the cytoplasm where it acti-
vates iron responsive elements.
DISCUSSION
While iron transport to developing organs is critical, the mole-
cules thatmediate this process remainpoorly understood.Genes
that deliver iron to some lineages do not seem to be needed
throughout the embryo. For example, TfR1/ cells can populate
developing organs (Ned et al., 2003), DMT1/mice still undergo
hepatic organogenesis (Gunshin et al., 2005), and mutations in
Steap3 (Ohgami et al., 2005) are compatible with development.
The candidate iron carrier Lcn2 is not essential in developmentDevelopmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc. 41
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Iron Traffic in the MetanephrosFigure 7. Scara5 Mediates Cellular Uptake of Ferritin-Bound Iron and Represents an Endogenous Pathway in MSC-1 Cells
(A) Capture of 59Fe-ferritin by Scara5+ at 37C (red line) but not at 4C (black line) nor by parental Trvb cells (blue line). Error bars indicate mean ± SD.
(B) Lysosomes of Scara5+ Trvb cells were marked with fluorescein-dextran (green). They contained endocytosed Alexa568-ferritin (red). Original magnification:
403.
(C) Transfer of iron to the cytoplasm was detected using two IRE-based iron reporters and FACS analysis in MSC-1 cells. The maximal 50IRE-CFP signal (desig-
nated 100%-black bars) was generated by iron loading with holotransferrin (20 mg/ml) and ferric ammonium citrate (20 mM) (HT+Fe) and the maximal 30 IRE-YFP
signal (designated 100%-stippled bars) was generated by DFO (20 mM). These treatments produced a 7-fold range in the ratio of 50/30 IRE signals. Treatment
with holoferritin (HF) increased 50IRE-CFP but decreased the 30IRE-YFP signal. Error bars indicate mean ± SD.
(D) Holoferritin induces cell growth. Scara5+ clone H responded to holo- but not to apo-ferritin, whereas Trvb cells failed to respond. Cell protein was detected by
GAPDH immunoblots.
(E) Alexa488-ferritin endocytosis was blocked by Poly I > Poly G > Poly C (50 mM). Similar data were obtained in Scara5+ Trvb and MSC1 cells. Bar = 20 mM.(Flo et al., 2004) and was even downregulated in the GFP-TfR1/
cell population, suggesting that it cannot compensate for TfR1/.
To determine the mechanism of iron delivery in the embryonic
kidney, we first examined the transferrin pathway. The most
striking finding was a restricted requirement for TfR1. For
example, thousands of differentiated kidney, gonad, bladder,
mid-gut, liver, and lung cells were generated from only 3–5
GFP-TfR1/ ES cells, implying that expression of TfR1 was not
required at any step of their lineage. In fact, we failed to visualize
an interaction of transferrin with GFP-TfR1/ cells (Thorstensen
et al., 1995), suggesting that they did not express anuncharacter-
ized transferrin receptor, although chimeric embryos in the hpx
background must be generated to formally test this idea. It also
remained possible that iron was supplied from immediately
adjacent TfR1+/+ mesenchyme or epithelia, but this idea was
effectively ruled out by the large clusters of differentiated
GFP-TfR1/ cells encompassing entire kidney compartments
(Figures 2A, 2D, and 2H; Figure S5D, R, BB). In sum, we found42 Developmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Ithat TfR1didnot limit thedevelopment ofmesenchyme, nephron,
stroma, or capsule cells, most likely because of transferrin-inde-
pendent pathways. In fact,whenwe introduced 55Feduring preg-
nancy (E11.5 or E12), 55Fe was uniformly distributed at E12.5
(Figure S10) despite variations in the expression of TfR1, again
implicating one or more non-transferrin mechanisms of iron
delivery in the kidney.
Extracellular ferritin may be a non-transferrin source of iron.
First, while serum ferritin is not thought to be a major iron carrier
in the adult, its concentration is nearly 3–8-fold higher in fetal
blood than that of themother (approximately 0.3 mg/ml; Puolakka
et al., 1980; Siddappa et al., 2007) and it has the potential to carry
a larger number of iron atoms/molecule than transferrin (Wata-
nabe et al., 2001; Levi et al., 1989, 1992). Second, extracellular
ferritin may be synthesized locally by macrophages (Leimberg
et al., 2008; Yuan et al., 2004), which are abundant inmetanephric
mesenchyme (Rae et al., 2007). During kidney development, 25%
of mesenchymal cells undergo apoptosis, and 3% of kidney cellsnc.
Developmental Cell
Iron Traffic in the Metanephrosare apoptotic at steady state (Koseki et al., 1992).While apoptotic
cells canbeclearedbyanumberofcell types, there is evidence for
macrophage involvement in the kidney (Camp andMartin, 1996).
Hence, ferritin may derive from serum, but may also be obtained
locally from macrophages, recycling iron from apoptotic cells.
The capture of ferritin was originally demonstrated in hepato-
cytes (Mack et al., 1983; Sibille et al., 1989), intestine (SanMartin
et al., 2008), white matter (Hulet et al., 1999), lymphoid cells
(Moss et al., 1992), erythroid precursors (Meyron-Holtz et al.,
1999), and in the capsule of the adult kidney (Kobayashi,
1978). In all of these cell types, ferritin used an endocytic
pathway (Hulet et al., 2000; Gelvan et al., 1996; Bretscher and
Thomson, 1983) and delivered iron to the cytoplasm (Radisky
and Kaplan, 1998; San Martin et al., 2008). Our studies have
added stroma of embryonic capsule to this long list of cells.
Scavenger receptors bind their ligands using a series of posi-
tively charged residues in the collagenous (Doi et al., 1993) or
cysteine-rich domains (Ojala et al., 2007). Using these residues
they bind lipopolysaccharides, bacteria, and polynucleotides,
all of which share repetitive polyanionic motifs (Jiang et al.,
2006). While iron carriers have not been studied as ligands for
scavenger receptors, ferritin contains repeating chains of polya-
nionic monomers, and like classical polyanionic ligands, its
binding was sensitive to polynucleotides. In this light, it is impor-
tant to determine whether ferritin binds to more than one scav-
enger receptor, or is uniquely bound by Scara5, particularly
given that Scara5 appears not to bind the typical ligands, such
as acetylated or oxidized LDL. Moreover, Scara3 (Han et al.,
1998) which was also expressed in renal stroma and capsule,
did not capture ferritin (data not shown). Hence, while we present
data demonstrating a Scara5-ferritin interaction, it is unresolved
whether Scara5 is a unique ferritin receptor component, or rather
simply an example of a common scavenger-ferritin interaction.
A number of functionsmay be served by a Scara5-ferritin inter-
action, in addition to supplying iron to the cell hosting the
receptor. These include transporting iron across a cellular layer.
The best studied model of iron transcytosis is the duodenal cell,
which provides ferroportin-dependent iron export. In an analo-
gous fashion, brain capillary cells (Fisher et al., 2007; Xu and
Ling, 1994) and placenta can also transfer iron in fact from
ferritin through ferroportin (Lamparelli et al., 1989; Bastin
et al., 2006). The renal capsule includes c-kit+flk+podocalyxin+
nascent capillaries (Schmidt-Ott et al., 2006) whichmay enhance
delivery of serum ferritin, while their expression of ferroportin
may export iron to adjacent stromal and mesenchymal cells.
Perhaps transcellular transport provides iron to developing
organs at critical stages prior to the completion of the vascular
tree. While such a mechanism remains speculative, it is sup-
ported by the coexpression of Scara5 and ferroportin in mesen-
chyme that surrounds proximal lung buds and by the expression
of Scara5 and ferroportin in thin layers of cells that surround
other developing organs.
In contrast to the widespread development of GFP-TfR1/
stroma, mesenchyme, and epithelia, we found limited develop-
mentofGFP-TfR1/ inureteric tips, suggesting their dependence
on transferrin. Similarly, while the lung was heavily populated by
GFP-TfR1/ cells, the tips of the airway had the fewest GFP-
TfR1/ cells compared with stalks or mesenchyme (Figure S4).
Because the expression of TfR1 has historically been linked toDevstages of cell proliferation (Kanayasu-Toyoda et al., 1999; Sposi
et al., 2000; Wingert et al., 2004), it is tempting to propose that
the high proliferative rate of tip cells in kidney and in lung (Michael
and Davies, 2004; Nogawa et al., 1998; Mollard and Dziadek,
1998) demands transferrin. While this model is compelling
because TfR1 is prominent in branching epithelia, this hypothesis
requires testing by measuring the relative proliferative rates of
different cell types at different stages in vivo and direct correlation
with the level of Tfr1 expression.
In sum, we have utilized a deletion of TfR1 to study iron trans-
port in embryonic kidney. This analysis was possible because
the second transferrin receptor (TfR2) had limited or no expres-
sion in the kidney as demonstrated by our gene arrays and by
in situ hybridization (data not shown). The data indicate that
Tf-TfR1 targets specific compartments rather than every cell
type. Transferrin is captured and required by the ureteric bud
tip after E11, but it is not required by metanephric mesenchyme
and is poorly internalized and not required by stromal and
capsular cells. We identified a novel ferritin receptor and suggest
that this pathway may support growth of kidney cells, not only in
capsule, but potentially in adjacent mesenchymal cells as well,
hence bypassing an overt requirement for TfR1.
EXPERIMENTAL PROCEDURES
TfR1 Knockout Embryos
TfR1+/ mice (Levy et al., 1999) were bred with C57BL/6J for five generations
and the alleles detected using radio- or 50Fam-labeled primers (Invitrogen) as
described (Levy et al., 1999).
GFP-TfR/ES Cells and Chimeric Embryos
The ROSA26-eGFP knockin construct (Srinivas et al., 2001) was reconstructed
with a puromycin selectable marker and introduced into Tfr1/ ES clones
(H5, E12; Ned et al., 2003). One hundred and ninety-two puromycin-resistant
(250 mg/ml) colonies were screened by Southern blot, by anti-CD71 (BD Phar-
Mingen) and by Alexa-568-holo-transferrin (20 mg/ml, 1 hr) endocytosis.
Chimeras were generated by introducing 3–5 GFP-TfR1/ or Tfr1+/+ ES
cells into wild-type C57BL/6 blastocysts. Chimeric tissues were analyzed in
permeabilized cryosections (0.1% Triton X-100/0.2% BSA in PBS for 15 min
at RT) with antibodies to pan Cytokeratin (1:300; Sigma), Pax-2 (1:100;
Zymed), Podocalyxin (1:300; R&D System), and Phospho-Histone3 (1:50;
Cell Signaling Technology). Alternatively, permeabilized cryosections (0.1%
Triton X-100 and 0.5% Saponin in PBS for 1 hr with 1% heat inactivated horse
serum at RT) were immunoassayed with E-Cadherin (1:400; R&D Systems),
Tenascin (1:400; Chemicon), TROMA-1 (1:20; Developmental Studies
Hybridoma Bank), active Caspase-3 (1:250; Promega), and ferritin (1:250;
Biogenesis) antibodies.
Microarray Analysis of GFP-TfR1/ Kidney Cells
Chimeric E15 kidneys from two independent litters were digested with collage-
nase (30 min) and trypsin (5 min), quenched with DMEM with 10% FCS, and
106 GFP-TfR1/ or TfR1+/+ cells collected by FACS. Total RNA (50 ng) was
biotin labeled using the Ovation Biotin System (NuGen) and cDNA (2.2 mg)
was hybridized in duplicate to Mouse Genome 430 2.0 Genechip arrays
(Affymetrix). Image files were analyzed by robust multichip analysis.
Real-time PCR amplification of Scara5 utilized forward (50tggggctgtatcttc
tggtc30) and reverse (50atcctgaaccttccacacct30) primers and iQ SYBRGreen
Super Mix (Biorad), cycled 95C/2 min, and 95C/30 s and 60C/30 s 3 50
cycles. Specificity was checked bymelting curve analysis and electrophoresis.
Scara5 expression was normalized to b-actin expression (forward 50ctaagg
ccaaccgtgaaaag30 and reverse 50tctcagctgtggtggtgaag30 primers) by DCT
method.elopmental Cell 16, 35–46, January 20, 2009 ª2009 Elsevier Inc. 43
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Full-length scara5 cDNA was cloned from mouse E15 Clontech cDNA library
by using a forward 50caccatggacaacaaagc30 and reverse 50 ggggacagtacaa
gtcac30 primers and pcDNA3.1 Directional TOPO expression plasmid.
Scara5-V5 was then amplified with primers 50gcggatccatggacaacaaagccat
gtac-30 that included a BamH1 site, and 50gcgtttaaactcacgtagaatcgagacc
gag-30 that included a PmeI site followed by ligation to pcDNA3.1+.
Trvb cells (a kind gift of McGraw et al., 1987) and MSC-1 cells (a kind gift of
McGuinness et al., 1994) were transfected with Scara5, selected with G418
(400 mg/ml) and authenticated by anti-V5 immunoblots (1:5,000 Invitrogen)
or immunofluorescence (1:2,000). Ferritin mediated growth in serum free
culture media was measured in 23 104 cells/well (60 hr) using GAPDH immu-
noblots (Abcam, 1:5,000).
Immunoprecipitation of Ferritin:Scara5 Complexes
Scara5+-Trvb clones were lysed (in 0.5% NP40, DNase I with protease inhib-
itors), sonicated (10 s, 4C), sheared with an insulin syringe 33 and centrifuged
(14,000 rpm; 20 min at 4C). The supernatant was diluted 2-fold, filtered (0.45
mm) and avidin-ferritin (20 mg; Sigma) or equimolar avidin (2.5 mg; Sigma) added
(3 hr). Immunoprecipitates were collected with Protein A and G Agarose Beads
(10 ml each; Boehringer-Mannheim) coated with V5 or IgG2a isotype-matched
antibodies (10 mg, Jackson Immunoresearch) for 3 hr and washed in PBS with
Ca, Mg, 0.5% NP40 (5 times). Avidin-ferritin was detected with biotin-HRP
(1 mg/ml in 1%BSA in TBST, Jackson Immunoresearch). The reciprocal immu-
noprecipitation was performed by coating Biotin-Agarose (10 ml) beads with
Avidin or Avidin-ferritin and detecting Scara5 by anti-V5 blots.
Binding and Endocytosis of Ferritin
5,6 carboxytetramethyl-rhodamine, Alexa568, and Alexa488 succinimidyl
ester (Molecular Probes) coupled apo-ferritin were authenticated by SDS-
PAGE after clean-up on a 100 KDa cut-off microcon. Cells were incubated
(37C; 30 hr) with fluorescent ferritin (2 mg/ml) and polynucleotides (50 mg/ml)
or untagged ferritin (100-fold excess) and fluorescence quantified by BD LSRII
flow cytometer and FloJo7.2.2 software. In some cases, cells were colabeled
with fluorescein-dextran (1mg/ml; 3 hr) followedbyovernightwashout. Surface
binding utilized apo-ferritin (100 mg/ml; 4C; 2hr) followed by immunodetection
in unpermeabilized cells with anti-ferritin (Biogenesis, 1:200) and anti-V5.
59Fe-ferritin was prepared by incubating apoferritin at a 1:10 ratio with 59Fe in
10 mM HCO3 at 37
C overnight, followed by clean-up on a 100 KDa cut-off
microcon. 59Fe-ferritin (3 3 104cpm) was added to 24-well plates containing
2 3 104 cells.
Iron reporter probes were introduced into MSC1 cells by adenoviral medi-
ated gene transfer. E1/E3 deleted type 5 adenoviral expression constructs
contained either a 50IRE upstream of destabilized ECFP or a 30IRE complex
downstream of destabilized EYFP. Virus was produced in 293A cells (Vira-
Power; Invitrogen) and purified on a CsCl step-gradient, followed by dialysis
and infected with MOI = 10.
Knockdown of Scara5 in MSC-1 Cells
U6 pEntry Vector (Invitrogen) was used to express hairpin RNAs encoding two
shRNA sequences unique to Scara5 (nucleotides 434–452 and 1222–1240;
GenBank Accession Number: BC016096) from annealed ssDNAs (1 mg/ml; In-
vitrogen). MSC-1 were transfected with pU6SR5 or pU6LacZ control plasmid,
selected with Blasticidin (2 mg/ml), and three anti-Scara5 siRNA oligos
(Ambion) were then transfected to increase the interference. Knockdown
was quantified by real-time PCR, incubation with FITC-ferritin (20 mg/ml; 2 hr
at 37C), and analysis by FACS.
In Situ Hybridization of Transferrin Receptor1 and Scara5
Digoxigenin-labeled (Roche) antisense riboprobes were generated from plas-
mids encoding TfR1 (1000 nt, exon 1–7) and Scara5 (1476 nt, exon 1–8).
Sections were stained with anti-digoxigenin (Boehringer-Mannheim; 1:5000
dilution; Schmidt-Ott et al., 2005).
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